• Biotech Stock Report

Citius Pharmaceuticals to Present at the ThinkEquity Conference

CRANFORD, N.J., May 1, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the ThinkEquity Conference on Thursday, May 2, 2019 at 8:30AM ET. The conference is being held at The Mandarin Oriental Hotel in New York City.

During the conference, Executive Chairman, Mr. Leonard Mazur will be giving the presentation as well as answering questions from investors. Citius Pharmaceuticals recently raised $5.3 million with 37% from coming from Mr. Leonard Mazur, Executive Chairman of Citius Pharmaceuticals and Mr. Myron Holubiak, President and CEO of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. will also be available for one-on-one meetings. To arrange a meeting with the Company, please contact Mr. Andrew Scott


© 2019 by Biotech Stock Report